# Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer

> **NCT03638765** · PHASE1 · UNKNOWN · sponsor: **Northwest Biotherapeutics** · enrollment: 24 (estimated)

## Conditions studied

- Brain Metastases
- Lung Cancer Metastatic
- Breast Cancer Metastatic

## Interventions

- **BIOLOGICAL:** DCVax-Direct

## Key facts

- **NCT ID:** NCT03638765
- **Lead sponsor:** Northwest Biotherapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11
- **Primary completion:** 2019-12
- **Final completion:** 2020-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2018-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03638765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03638765, "Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03638765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*